+

WO2003033668A3 - Correlation entre l'expression genique et les aberrations chromosomiques dans l'oncogenese de l'ataxie telangiectasie - Google Patents

Correlation entre l'expression genique et les aberrations chromosomiques dans l'oncogenese de l'ataxie telangiectasie Download PDF

Info

Publication number
WO2003033668A3
WO2003033668A3 PCT/US2002/033311 US0233311W WO03033668A3 WO 2003033668 A3 WO2003033668 A3 WO 2003033668A3 US 0233311 W US0233311 W US 0233311W WO 03033668 A3 WO03033668 A3 WO 03033668A3
Authority
WO
WIPO (PCT)
Prior art keywords
tumorigenesis
correlation
gene expression
ataxia telangiectasia
chromosome abnormalities
Prior art date
Application number
PCT/US2002/033311
Other languages
English (en)
Other versions
WO2003033668A2 (fr
Inventor
Carrolee Barlow
Christopher J Winrow
Marie Lei A Callahan
Daniel G Pankratz
Cecile Rose T Vibat
Amy J Warren
Original Assignee
Digital Gene Tech Inc
Carrolee Barlow
Christopher J Winrow
Marie Lei A Callahan
Daniel G Pankratz
Cecile Rose T Vibat
Amy J Warren
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Digital Gene Tech Inc, Carrolee Barlow, Christopher J Winrow, Marie Lei A Callahan, Daniel G Pankratz, Cecile Rose T Vibat, Amy J Warren filed Critical Digital Gene Tech Inc
Priority to AU2002349956A priority Critical patent/AU2002349956A1/en
Priority to EP02786436A priority patent/EP1608390A2/fr
Publication of WO2003033668A2 publication Critical patent/WO2003033668A2/fr
Publication of WO2003033668A3 publication Critical patent/WO2003033668A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne des polynucléotides, des polypeptides, des nécessaires et des méthodes associés à des caractéristiques de gènes régulés de l'oncogenèse de l'ataxie télangiectasie.
PCT/US2002/033311 2001-10-17 2002-10-17 Correlation entre l'expression genique et les aberrations chromosomiques dans l'oncogenese de l'ataxie telangiectasie WO2003033668A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2002349956A AU2002349956A1 (en) 2001-10-17 2002-10-17 Correlation of gene expression with chromosome abnormalities in ataxia telangiectasia tumorigenesis
EP02786436A EP1608390A2 (fr) 2001-10-17 2002-10-17 Correlation entre l'expression genique et les aberrations chromosomiques dans l'oncogenese de l'ataxie telangiectasie

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33020601P 2001-10-17 2001-10-17
US60/330,206 2001-10-17

Publications (2)

Publication Number Publication Date
WO2003033668A2 WO2003033668A2 (fr) 2003-04-24
WO2003033668A3 true WO2003033668A3 (fr) 2004-09-16

Family

ID=23288744

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/033311 WO2003033668A2 (fr) 2001-10-17 2002-10-17 Correlation entre l'expression genique et les aberrations chromosomiques dans l'oncogenese de l'ataxie telangiectasie

Country Status (3)

Country Link
EP (1) EP1608390A2 (fr)
AU (1) AU2002349956A1 (fr)
WO (1) WO2003033668A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7034144B2 (en) 1997-05-13 2006-04-25 Erasmus Universiteit Rotterdam Molecular detection of chromosome aberrations
US7105294B2 (en) 1998-05-04 2006-09-12 Dako Denmark A/S Method and probes for the detection of chromosome aberrations

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BISHOP A. ET AL: "Atm deficiency causes an increased frequency of intrachromosomal homologous recombination in mice", CANCER RESEARCH, vol. 60, no. 2, 15 January 2000 (2000-01-15), pages 395 - 399, XP002978686 *
DATABASE GENBANK [online] 17 December 1998 (1998-12-17), MARRA ET AL: "The WashU-HHMI Mouse EST Project", XP002978683, accession no. EST Database accession no. (AI315667) *
DATABASE GENBANK [online] 30 June 2000 (2000-06-30), OSADA ET AL: "Isolation of full-length cDNA clones from mouse brain cDNA library made by oligo-capping method", XP002978684, accession no. EST Database accession no. (AB041555) *
LIYANAGE M. ET AL: "Abnormal rearrangement within the alpha/delta T-cell receptor locus in lymphomas from Atm-deficient mice", BLOOD, vol. 96, no. 5, 1 September 2000 (2000-09-01), pages 1940 - 1946, XP002978685 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7034144B2 (en) 1997-05-13 2006-04-25 Erasmus Universiteit Rotterdam Molecular detection of chromosome aberrations
US7105294B2 (en) 1998-05-04 2006-09-12 Dako Denmark A/S Method and probes for the detection of chromosome aberrations
US7368245B2 (en) 1998-05-04 2008-05-06 Dako Denmark A/S Method and probes for the detection of chromosome aberrations
US7642057B2 (en) 1998-05-04 2010-01-05 Dako Denmark A/S Method and probes for the detection of chromosome aberrations

Also Published As

Publication number Publication date
AU2002349956A1 (en) 2003-04-28
EP1608390A2 (fr) 2005-12-28
WO2003033668A2 (fr) 2003-04-24

Similar Documents

Publication Publication Date Title
WO2004000102A3 (fr) Procede servant a predire une reponse a une therapie dirigee vers le recepteur du facteur de croissance epidermique
AU2003212954A1 (en) Skin cell biomarkers and methods for identifying biomarkers using nucleic acid microarrays
AU2003237788A1 (en) Electrode constructs, and related cells and methods
AU2003301997A1 (en) Gene elevating cereal yield and utilization thereof
WO2004047514A3 (fr) Procedes pour identifier des risques de cancer du sein, et traitements correspondants
WO2005027886A3 (fr) Methodes de prevention ou de traitement de la recurrence de l'infarctus du myocarde
WO2005014846A3 (fr) Procedes pour reperer le risque de cancer du sein et traitements correspondants
TW200506052A (en) Method of analyzing DNA region
WO2003033668A3 (fr) Correlation entre l'expression genique et les aberrations chromosomiques dans l'oncogenese de l'ataxie telangiectasie
WO2004029283A3 (fr) Sondes d'adn subtelomeriques et leur procede de production
EP1567644A4 (fr) Genes et batteries de genes specifiques de tissus
WO2005030788A3 (fr) Procede de detection precoce non invasive de cancer du colon et/ou de precurseurs du cancer du colon
EP1385866A4 (fr) Sequences nucleotidiques regulatrices d'alcool oxydase 1 pour l'expression de genes heterologues dans une levure
AU2003267513A1 (en) Chromosome 3, 5 and 11 genes involved in premature canities
AU2003244340A1 (en) Method for specific integration of t7 rna polymerase gene in the chromosome of corynebacterial and the resultant corynebacteria-t7 promoter based shuttle vector system.
AU2003285583A1 (en) Oligonucleotide guided analysis of gene expression
WO2004048546A3 (fr) Procedes permettant de detecter le risque de cancer du sein et traitements pour ce dernier
AU2003296087A1 (en) Nucleotide derivatives and dna microarray
WO2002031114A3 (fr) Expression genique module dans l'ileite
WO2002010203A3 (fr) Genes daz
AU2003275946A1 (en) Gene expression in biological conditions
WO2000077166A3 (fr) Expression genique modulee dans des inflammations gastro-intestinales
AU2002364153A1 (en) Genetic analysis of gene expression in heterosis
WO2001029179A3 (fr) Regulation de l'expression genetique par des neuromodulateurs
WO2004001003A9 (fr) Division plastidique, genes et proteines correspondants ainsi que procedes d'utilisation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VC VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2002786436

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002786436

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWR Wipo information: refused in national office

Ref document number: 2002786436

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2002786436

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载